In the review “Pituitary-targeted medical therapy of Cushing's disease”, published in the May 2008 issue of Expert Opinion on Investigational Drugs (Expert Opin. Investig. Drugs (2008) 17(5):669-77), there was a mistake in the declaration of interest statement. The correct statement is shown below:
AB Grossman has received lecture fees from and been on the advisory board of Novartis. KI Alexandraki declares no conflicts of interest. No payment was received for preparation of this manuscript.
The publishers sincerely regret any inconvenience that this error may have caused.